415952

Sigma-Aldrich

Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide

97%

Synonym(s):
2,4,6-Trimethylbenzoylphenyl phosphinate, (Diphenylphosphoryl)(mesityl)methanone, (2,4,6-Trimethylbenzoyl)diphenylphosphine oxide
Linear Formula:
(CH3)3C6H2COP(O)(C6H5)2
CAS Number:
Molecular Weight:
348.37
EC Number:
MDL number:
PubChem Substance ID:
NACRES:
NA.23

Quality Level

assay

97%

mp

88-92 °C (lit.)

SMILES string

Cc1cc(C)c(c(C)c1)C(=O)P(=O)(c2ccccc2)c3ccccc3

InChI

1S/C22H21O2P/c1-16-14-17(2)21(18(3)15-16)22(23)25(24,19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-15H,1-3H3

InChI key

VFHVQBAGLAREND-UHFFFAOYSA-N

Related Categories

General description

Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide (TPO) is a monoacylphosphine oxide based photoinitiator that can be incorporated in a variety of polymeric matrixes for efficient curing and color stability of the resin.

Application

TPO can be used in the photo-crosslinking of PMMA composite, which can further be used as a gate insulator in organic thin film transistors (OTFTs). It can also be used in the formation of UV curable urethane-acrylate coatings. It may also be used in the photoinduced reaction for the formation of organophosphine compounds, which potentially find their usage as ligands with metal catalysts and reagents.

Packaging

10, 50 g in poly bottle

Storage and Stability

light sensitive

Signal Word

Warning

Hazard Statements

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

RIDADR

UN 3077 9 / PGIII

WGK Germany

WGK 2

Certificate of Analysis

Certificate of Origin

PMMA-based patternable gate insulators for organic thin-film transistors
Kim TG, et al.
Synthetic Metals, 159(7-8), 749-753 (2009)
Ela Sachyani Keneth et al.
Polymers, 12(3) (2020-03-27)
Shape memory polymers are attractive smart materials that have many practical applications and academic interest. Three-dimensional (3D) printable shape memory polymers are of great importance for the fabrication of soft robotic devices due to their ability to build complex 3D...
Andrew V Healy et al.
Pharmaceutics, 11(12) (2019-12-11)
The introduction of three-dimensional printing (3DP) has created exciting possibilities for the fabrication of dosage forms, paving the way for personalized medicine. In this study, oral dosage forms of two drug concentrations, namely 2.50% and 5.00%, were fabricated via stereolithography...
Monomer-to-polymer conversion and micro-tensile bond strength to dentine of experimental and commercial adhesives containing diphenyl (2, 4, 6-trimethylbenzoyl) phosphine oxide or a camphorquinone/amine photo-initiator system
Miletic V, et al.
Journal of Dentistry, 41(10), 918-926 (2013)
I Capasso et al.
Scientific reports, 10(1), 612-612 (2020-01-19)
Motivated by the hierarchical micro and nanoscale features in terms of porosity of diatomite, the production of ceramic-graded porous foams with tailored porosity, obtained by using it as raw material, has been proposed. The main challenge during the foam-production process...
Articles
The manufacture of monomers for use in ophthalmic applications is driven by the need for higher purity, improved reliability of manufacturing supply, but ultimately by the need for the increased comfort, convenience, and safety of contact lens wearers. Daily wear contact lenses have the potential to fill this need for many customers; however, their widespread use is constrained by higher costs compared to weekly- or monthly-based lenses. New approaches that improve cost structure and result in higher quality raw materials are needed to help make contact lenses more affordable and accelerate growth of the contact lens market.
Read More

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.